Linezolid Tablet, Film Coated
Product Images NDC 31722-749

4 FDA label images from Camber Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Linezolid (NDC 31722-749). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

Fig1 (Fig1)
Chemical structure of linezolid, the active ingredient depicted as a molecular diagram showing its ring systems, functional groups, and bonds.*
FDA Label Image

Fig2 (Fig2)

Fig2 (Fig2)
A line graph depicting plasma concentrations of Linezolid over time following a 600 mg oral dose every 12 hours. The x-axis represents time in hours after dosing, and the y-axis shows Linezolid plasma concentration in mcg/mL. Data points include error bars indicating variability at each time point.*
FDA Label Image

Camber1

FDA Label Image

Label

Label
Linezolid 600 mg film-coated tablets carton label by Camber Pharmaceuticals, Inc. The label states the active ingredient is linezolid, with 20 tablets per package. It includes storage instructions, a barcode, and manufacturing information by Camber Pharmaceuticals, Inc. and Hetero Labs Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.